4.82 USD
+0.24 (+5.24%)
AT CLOSE (11:59 AM EDT)
Abeona Therapeutics Inc. Common Stock (ABEO)
NASDAQ: ABEO • USD
4.83
+0.03 (+0.62%)
POST MARKET (AS OF 04:28 PM EDT)
Market: OPEN
Open?$4.50
High?$4.84
Low?$4.50
Prev. Close?$4.58
Volume?761.9K
Avg. Volume?1.4M
VWAP?$4.78
Rel. Volume?0.56x
Bid / Ask
Bid?$4.81 × 100
Ask?$5.59 × 100
Spread?$0.78
Midpoint?$5.20
Valuation & Ratios
Market Cap?261.3M
Shares Out?57.0M
Float?48.1M
Float %?88.8%
P/E Ratio?3.67
P/B Ratio?1.64
EPS?$1.25
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.93Strong
Quick Ratio?6.74Strong
Cash Ratio?2.65Strong
Debt/Equity?0.13Low
ValuationFAIRLY VALUED
Score73/100
P/E?3.7CHEAP▾
P/B?1.64CHEAP▾
P/S?44.89HIGH▾
P/FCF?N/A▾
EV/EBITDA?-2.3CHEAP▾
EV/Sales?34.86HIGH▾
Returns & Efficiency
ROE?44.7%STRONG▾
ROA?32.4%STRONG▾
Cash Flow & Enterprise
FCF?$-84301000
Enterprise Value?$202.9M
Related Companies
Loading...
News
Profile
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Employees
226
Market Cap
261.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1980-09-19
Address
6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND, OH 44103
Phone: 646-813-4701
CLEVELAND, OH 44103
Phone: 646-813-4701